Jefferies Financial Group Inc. Has $1.53 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Jefferies Financial Group Inc. cut its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 99.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,580 shares of the biotechnology company’s stock after selling 262,420 shares during the period. Jefferies Financial Group Inc.’s holdings in Axon Enterprise were worth $1,533,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in AXON. New Wave Wealth Advisors LLC acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $40,000. Y.D. More Investments Ltd acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $45,000. Stonebridge Financial Group LLC acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $53,000. GPS Wealth Strategies Group LLC raised its holdings in Axon Enterprise by 74.1% during the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock worth $56,000 after purchasing an additional 40 shares during the last quarter. Finally, Berbice Capital Management LLC bought a new position in Axon Enterprise during the 4th quarter worth approximately $59,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Needham & Company LLC raised their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a report on Thursday, May 8th. Barclays raised their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a report on Friday, May 9th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a report on Wednesday. One analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $652.73.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $728.53 on Thursday. The company has a fifty day moving average of $576.22 and a 200-day moving average of $589.48. The firm has a market capitalization of $56.72 billion, a P/E ratio of 188.25, a P/E/G ratio of 5.17 and a beta of 1.24. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $732.17.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. Axon Enterprise’s revenue for the quarter was up 31.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.15 EPS. As a group, sell-side analysts anticipate that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CFO Brittany Bagley sold 3,400 shares of the business’s stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $700.00, for a total transaction of $2,380,000.00. Following the completion of the sale, the chief financial officer now owns 131,833 shares in the company, valued at approximately $92,283,100. The trade was a 2.51% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Matthew R. Mcbrady sold 400 shares of the business’s stock in a transaction on Wednesday, May 14th. The shares were sold at an average price of $718.40, for a total transaction of $287,360.00. Following the sale, the director now owns 3,492 shares of the company’s stock, valued at $2,508,652.80. This trade represents a 10.28% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 23,764 shares of company stock worth $14,856,635. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.